As of 4:15pm ET
| -0.06 / -1.44%|
The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 6.00. The median estimate represents a +142.72% increase from the last price of 4.12.
The current consensus among 7 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.